Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazunori Nakayama

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Surgical Case Reports|April 27, 2026
Extraskeletal osteosarcoma in the rectus abdominis muscle: a case reportKazunori Nakayama, Hideki Ueda, Kento Fukaya, et al.
Oncology Reports|March 22, 2022
Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review)Hideya Onishi, Katsuya Nakamura, Kosuke Yanai, et al.
International Journal of Nephrology and Renovascular Disease|January 1, 2014
Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidismKazunori Nakayama, Kazushi Nakao, Yuji Takatori, et al.
Physical Review Letters|May 1, 2026
Detecting Dark Matter Using Optically Trapped Rydberg Atom Tweezer ArraysSo Chigusa, Taiyo Kasamaki, Toshi Kusano, et al.
Anticancer Research|December 1, 2017
Liprin-α4 as a Possible New Therapeutic Target for Pancreatic CancerAkio Yamasaki, Kazunori Nakayama, Akira Imaizumi, et al.
Journal of Medical Case Reports|July 28, 2024
Preserved walking function without postoperative reconstruction for pelvic Ewing's sarcoma: a case reportKazunori Nakayama, Seiji Shimomura, Toshiharu Shirai, et al.
Cellular Immunology|November 2, 2020
NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytesKazunori Nakayama, Hideya Onishi, Akiko Fujimura, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2019
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitorAkiko Fujimura, Kazunori Nakayama, Akira Imaizumi, et al.
Oncology Reports|March 2, 2021
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancerShu Ichimiya, Hideya Onishi, Shinjiro Nagao, et al.
Anticancer Research|July 20, 2021
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic CancerYasuhiro Oyama, Shinjiro Nagao, Lin Na, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Surgical Case Reports|April 27, 2026
Extraskeletal osteosarcoma in the rectus abdominis muscle: a case reportKazunori Nakayama, Hideki Ueda, Kento Fukaya, et al.
Oncology Reports|March 22, 2022
Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review)Hideya Onishi, Katsuya Nakamura, Kosuke Yanai, et al.
International Journal of Nephrology and Renovascular Disease|January 1, 2014
Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidismKazunori Nakayama, Kazushi Nakao, Yuji Takatori, et al.
Physical Review Letters|May 1, 2026
Detecting Dark Matter Using Optically Trapped Rydberg Atom Tweezer ArraysSo Chigusa, Taiyo Kasamaki, Toshi Kusano, et al.
Anticancer Research|December 1, 2017
Liprin-α4 as a Possible New Therapeutic Target for Pancreatic CancerAkio Yamasaki, Kazunori Nakayama, Akira Imaizumi, et al.
Journal of Medical Case Reports|July 28, 2024
Preserved walking function without postoperative reconstruction for pelvic Ewing's sarcoma: a case reportKazunori Nakayama, Seiji Shimomura, Toshiharu Shirai, et al.
Cellular Immunology|November 2, 2020
NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytesKazunori Nakayama, Hideya Onishi, Akiko Fujimura, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2019
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitorAkiko Fujimura, Kazunori Nakayama, Akira Imaizumi, et al.
Oncology Reports|March 2, 2021
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancerShu Ichimiya, Hideya Onishi, Shinjiro Nagao, et al.
Anticancer Research|July 20, 2021
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic CancerYasuhiro Oyama, Shinjiro Nagao, Lin Na, et al.
Pageof 2